SCHEMBL708379

SCHEMBL708379

COc1cc(OC)cc(C(=O)c2nc3ccc(OCC(=O)O)cc3n2CCc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.51
LMNA P02545 2/20 0.51
ACSS2 Q9NR19 2/20 0.48
KDM4E B2RXH2 2/20 0.48
PPARG P37231 3/20 0.46
PSEN1 P49768 4/20 0.44
PSEN2 P49810 4/20 0.44
APH1B Q8WW43 4/20 0.44
NCSTN Q92542 4/20 0.44
APH1A Q96BI3 4/20 0.44
PSENEN Q9NZ42 4/20 0.44
ALDH1A1 P00352 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MCL1 Q07820 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL707552 0.86 POLB (0.50) POLBLMNAKDM4EALDH1A1RECQL
SCHEMBL707714 0.83 LPAR1 (0.51) POLBLMNAKDM4EPPARGPSEN1
SCHEMBL709317 0.82 MCL1 (0.47) POLBLMNAKDM4EPPARGALDH1A1
SCHEMBL704971 0.81 PPARG (0.48) POLBLMNAKDM4EPPARGALDH1A1
SCHEMBL707130 0.80 PPARG (0.54) POLBLMNAKDM4EPPARG
SCHEMBL708371 0.80 POLB (0.54) POLBLMNAKDM4EALDH1A1RECQL
SCHEMBL709389 0.73 PSEN1 (0.55) POLBLMNAKDM4EPPARGPSEN1
SCHEMBL705825 0.73 SRD5A2 (0.57) POLBKDM4EALDH1A1
SCHEMBL6047767 0.72 POLB (0.57) POLBLMNAACSS2KDM4EALDH1A1
SCHEMBL4696808 0.72 POLB (0.57) POLBLMNAACSS2KDM4EPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1553075-B1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO (JP) 2013-08-14 EP disclosed
EP-2565178-A1 LPA Receptor Antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 2013-03-06 EP disclosed
US-20120088782-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-12 US disclosed
US-8124645-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2012-02-28 US disclosed
US-7820682-B2 LPA receptor antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-26 US disclosed
US-20100249157-A2 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-30 US disclosed
US-20080293764-A1 LPA RECEPTOR ANTAGONIST ONO PHARMACEUTICAL CO., LTD. 2008-11-27 US disclosed
US-20060148830-A1 Lpa receptor antagonist ONO PHARMACEUTICAL CO., LTD. 2006-07-06 US disclosed
EP-1553075-A1 LPA RECEPTOR ANTAGONISTS ONO PHARMACEUTICAL CO., LTD. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293764-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 POLB 1235/4885LMNA 1108/4885ACSS2 182/4885
US-20100249157-A2 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 POLB 1235/4885LMNA 1108/4885ACSS2 182/4885
US-20120088782-A1 LPA RECEPTOR ANTAGONIST LPAR1, LPAR2, LPAR4 POLB 1235/4885LMNA 1108/4885ACSS2 182/4885
US-20060148830-A1 Lpa receptor antagonist LPAR1, LPAR2, LPAR4 POLB 1235/4885LMNA 1108/4885ACSS2 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.